Primary Hyperparathyroidism Presenting as Posterior Reversible Encephalopathy Syndrome: A Report of Two Cases
PDF

Case Report

Primary Hyperparathyroidism Presenting as Posterior Reversible Encephalopathy Syndrome: A Report of Two Cases

J Clin Res Pediatr Endocrinol 2020;12(4):432-438 DOI: 10.4274/jcrpe.galenos.2020.2019.0181
, , , , , ,
PDF
Permissions

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinico-radiological entity characterized by subcortical vasogenic edema presenting with acute neurological symptoms. Common precipitating causes include renal failure, pre-eclampsia/eclampsia, post-organ transplant, and cytotoxic drugs. Hypercalcemia is a rare cause of PRES; most cases occur in the setting of severe hypercalcemia secondary to malignancy or iatrogenic vitamin D/calcium overdose. Primary hyperparathyroidism (PHPT), as a cause of PRES, is an oddity. We report two cases of adolescent PHPT presenting with generalized tonic-clonic seizures and altered sensorium. On evaluation, both had hypertension, severe hypercalcemia (serum calcium 14.1 mg/dL and 14.5 mg/dL, respectively) and elevated parathyroid hormone levels. Magnetic resonance imaging (MRI) revealed T2/fluid-attenuated inversion recovery hyperintensities located predominantly in the parieto-occipital regions, suggestive of PRES. Identification and excision of parathyroid adenoma led to the restoration of normocalcemia. Neurological symptoms and MRI changes improved subsequently. An extensive literature search revealed only four cases of PHPTassociated PRES; none of them being in the pediatric/adolescent age group. The predominant clinical manifestations were seizures and altered sensorium. All had severe hypercalcemia; three had hypertension at presentation, while one was normotensive. Parathyroid adenomectomy led to normalization of serum calcium and resolution of neurological symptoms and radiological changes. Thus, severe hypercalcemia, although rare in PHPT, can lead to hypercalcemic crisis precipitating acute hypertension that can result in cerebral endothelial dysfunction with the breakdown of the blood-brain barrier, culminating in PRES. We therefore recommend that serum calcium levels should be checked in all patients with PRES and that PHPT be regarded as a differential diagnosis in those with underlying hypercalcemia.

Keywords: Hypercalcemia, posterior reversible encephalopathy syndrome, primary hyperparathyroidism

Read the full text

3 sections · 3 figures · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.

References

1

Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 2015;14:914-925. Epub 2015 Jul 13

2

Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008;29:1036-1042.

3

Moussawi K, Meltzer EI, Levin SN, Prasad S. Paraneoplastic PRES from lymphoma induced hypercalcemia: case report and review of the literature. eNeurological Sci 2018;13:24-25.

4

Nakajima N, Ueda M, Nagayama H, Yamazaki M, Katayama Y. Posterior reversible encephalopathy syndrome due to hypercalcemia associated with parathyroid hormone-related peptide: a case report and review of the literature. Intern Med 2013;52:2465-2468.

5

Kastrup O, Maschke M, Wanke I, Diener HC. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 2002;249:1563-1566.

6

Camara-Lemarroy CR, Gonzalez-Moreno EI, Ortiz-Corona J de J, Yeverino-Castro SG, Sanchez-Cardenas M, Nuñez-Aguirre S, Villarreal-Alarcon MA, Galarza-Delgado DA. Posterior reversible encephalopathy syndrome due to malignant hypercalcemia: physiopathological considerations. J Clin Endocrinol Metab 2014;99:1112-1116. Epub 2014 Jan 29

7

Chen TH, Huang CC, Chang YY, Chen YF, Chen WH, Lai SL. Vasoconstriction as the etiology of hypercalcemia-induced seizures. Epilepsia 2004;45:551-554.

8

Kaplan PW. Reversible hypercalcemic cerebral vasoconstriction with seizures and blindness: a paradigm for eclampsia? Clin Electroencephalogr 1998;29:120-123.

9

Bolanthakodi N, Vidyasagar S, Varma M, Holla A. Posterior reversible encephalopathy syndrome due to hypercalcaemia: a rare cause. BMJ Case Rep 2019;12:223415.

10

Ahmed S, Wai P, Silverdale M. Posterior encephalopathy: an uncommon manifestation of calcium toxicity. Indian J Endocrinol Metab 2012;16:318-320.

11

Choudhary M, Rose F. Posterior reversible encephalopathic syndrome due to severe hypercalcemia in AIDS. Scand J Infect Dis 2005;37:524-526.

12

Kim JH, Kim MJ, Kang JK, Lee SA. Vasogenic edema in a case of hypercalcemia-induced posterior reversible encephalopathy. Eur Neurol 2005;53:160-162. Epub 2004 May 28

13

Au S, Dunham M, Godinez T. Treatment of medically refractory hypercalcemic crisis. Int J Artif Organs 2012;35:538-541.

14

Giani L, Lovati C, Bana C, Cova I, De Angeli F, CM D’Alessandro, Mariani C. Sub-acute posterior reversible encephalopathy associated with extrapyramidal signs induced by primary hyperparathyroidism: a case report and a revision of literature. Int Neuropsychiatr Dis J 2014;2:13-20.

15

Popkirov S, Figge A, Schlegel U, Skodda S. Tertiary hyperparathyroidism presenting as posterior reversible encephalopathy syndrome. Neurology 2016;86:695-696.

16

Salcuni AS, Cetani F, Guarnieri V, Nicastro V, Romagnoli E, de Martino D, Scillitani A, Cole DEC. Parathyroid carcinoma. Best Pract Res Clin Endocrinol Metab 2018;32:877-889. Epub 2018 Dec 1

17

Betea D, Potorac I, Beckers A. Parathyroid carcinoma: challenges in diagnosis and treatment. Ann Endocrinol (Paris) 2015;76:169-177. Epub 2015 Apr 21

18

Dutta A, Pal R, Jain N, Dutta P, Rai A, Bhansali A, Behera A, Nahar Saikia U, Vishwajeet V, Collier D, Boon H, Korbonits M, Bhadada SK. Pediatric parathyroid carcinoma: a case report and review of the literature. J Endocr Soc 2019;3:2224-2235.

19

Roizen J, Levine MA. Primary hyperparathyroidism in children and adolescents. J Chin Med Assoc 2012;75:425-434. Epub 2012 Aug 21

20

Endo A, Fuchigami T, Hasegawa M, Hashimoto K, Fujita Y, Inamo Y, Mugishima H. Posterior reversible encephalopathy syndrome in childhood: report of four cases and review of the literature. Pediatr Emerg Care 2012;28:153-157.

21

Emeksiz S, Kutlu NO, Caksen H, Alkan G, Seker Yikmaz H, Tokgoz H. Posterior reversible encephalopathy syndrome in children: a case series. Turk Pediatri Ars 2016;51:217-220.

22

Ou S, Xia L, Wang L, Xia L, Zhou Q, Pan S. Posterior reversible encephalopathy syndrome with isolated involving infratentorial structures. Front Neurol 2018;9:843.

23

Rabinstein AA, Mandrekar J, Merrell R, Kozak OS, Durosaro O, Fugate JE. Blood pressure fluctuations in posterior reversible encephalopathy syndrome. J Stroke Cerebrovasc Dis 2012;21:254-258. Epub 2011 May 4

24

Eiam-Ong S, Eiam-Ong S, Punsin P, Sitprija V, Chaiyabutr N. Acute hypercalcemia-induced hypertension: the roles of calcium channel and alpha-1 adrenergic receptor. J Med Assoc Thai 2004;87:410-418.

25

Režić-Mužinić N, Čikeš-Čulić V, Božić J, Tičinović-Kurir T, Salamunić I, Markotić A. Hypercalcemia induces a proinflammatory phenotype in rat leukocytes and endothelial cells. J Physiol Biochem 2013;69:199-205. Epub 2012 Aug 9

26

Chen HI, Yeh DY, Kao SJ. The detrimental role of inducible nitric oxide synthase in the pulmonary edema caused by hypercalcemia in conscious rats and isolated lungs. J Biomed Sci 2008;15:227-238. Epub 2007 Sep 29

27

Shiraishi N, Kitamura K, Kohda Y, Narikiyo T, Adachi M, Miyoshi T, Iwashita K, Nonoguchi H, Miller RT, Tomita K. Increased endothelin-1 expression in the kidney in hypercalcemic rats. Kidney Int 2003;63:845-852.

28

Bhadada SK, Arya AK, Mukhopadhyay S, Khadgawat R, Sukumar S, Lodha S, Singh DN, Sathya A, Singh P, Bhansali A. Primary hyperparathyroidism: insights from the Indian PHPT registry. J Bone Miner Metab 2018;36:238-245. Epub 2017 Mar 31

29

Ackerman NB, Winer N. The differentiation of primary hyperparathyroidism from the hypercalcemia of malignancy. Ann Surg 1975;181:226-231.

30

Okaygün P, Sav H, Mousa U, Esatoğlu V, Küçük T, Köseoğluları O, Buyuk S. Parathyroid Adenoma Complicated with Severe Hypercalcemia, Encephalopathy and Pancreatitis. Turk J Endocrinol Metab 2015;19:105-108.